secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turn Therapeutics Inc. (TTRX)
CIK:        0002023016
Form:       8-K
Filed at:   2026-06-03T10:12:38+00:00
Accession:  0001213900-26-064405
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turn Therapeutics releases investor presentation at Jefferies conference; no new material disclosures
--------------------------------------------------------------------------------

- Investor presentation dated June 3, 2026, released for the Jefferies Global Healthcare Conference.
- Presentation does not contain specific financial or operational updates beyond prior disclosures.
- No changes to guidance, pipeline, or corporate strategy reported in the filing or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026064405/0001213900-26-064405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026064405/ea0293128-8k_turn.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-064405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer